Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Guido Marcucci Kati Maharry Krzysztof Mrózek Clara D. Bloomfield Christian Thiede Peter Paschka Richard A. Larson |
| Publication date | June 16, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |